WESPAC Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-670
Closed -$280K 184
2024
Q1
$280K Hold
670
0.16% 145
2023
Q4
$273K Hold
670
0.19% 124
2023
Q3
$233K Buy
+670
New +$233K 0.17% 125
2019
Q2
Sell
-3,361
Closed -$618K 144
2019
Q1
$618K Buy
+3,361
New +$618K 0.43% 68
2018
Q4
Sell
-1,319
Closed -$254K 165
2018
Q3
$254K Buy
+1,319
New +$254K 0.15% 124
2018
Q2
Sell
-5,321
Closed -$867K 148
2018
Q1
$867K Buy
+5,321
New +$867K 0.53% 60